BIOVECTRA is honored with 2025 CDMO Leadership Award for biologics

BIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex chemistry, proudly announces it is the recipient of the 2025 Outsourced Pharma CDMO Leadership Award in the category of biologics.

Statin-Antibiotic Combo Shows No Benefit for Decompensated Cirrhosis

Adding simvastatin and rifaximin to standard therapy for decompensated cirrhosis does not improve clinical outcomes, a double-blind phase III trial showed. For the primary endpoint,

February 6, 2025

Hunger hormone suppressed by intense exercise, study suggests

Research shows high-intensity exercise suppresses appetite by lowering ghrelin levels, with distinct responses observed between male and female participants.

October 28, 2024

Sanofi resolves most Zantac litigation

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey! Meghana here. Today,

April 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.